QNTM: Quantum BioPharma Ltd. Sotuvning operatsion marjasi

Quantum BioPharma Corp - QNTM emitenti grafik logotipi

Quantum BioPharma Ltd (QNTM) markaziy nerv tizimi patologiyalari va yallig'lanish bo'yicha tadqiqot va ishlanmalarini kengaytirmoqda hamda B2B sherikliklari orqali o'sishni maqsad qilgan. GURU.Markets tomonidan taqdim etilgan operatsion marja tarixi moliyaviy barqarorlikni yaqqol ko'rsatadi, bunda 0.00 qiymati joriy ko'rsatkichni ifodalaydi. Shu bilan birga, kompaniya uglerod izini kamaytirish uchun ESG standartlarini joriy qilmoqda, garchi spekulyativ kapital oqimlari va qat'iy tartibga soluvchi nazorat uning diversifikatsiyalashgan ekotizimi barqarorligini cheklayotgan bo'lsa-da.

QNTM - Quantum BioPharma Operatsion marja 16.08.2024 - 19.11.2026 oraligʻida

Quantum BioPharma Ltd - tahliliy kesimlar va asosiy koʻrsatkichlar (QNTM)

Kompaniyaning jamlanma tahlili:Quantum BioPharma Corp, QNTM
Quantum BioPharma Corp brendining mahsuloti

Operatsion marja daromadning har bir dollari uchun asosiy operatsiyalardan olingan foyda ulushini o'lchaydi, bu esa investorlarga foizlar va soliqlar to'lovigacha bo'lgan operatsion rentabellikdan foydalanib, haqiqiy biznes jarayonlari samaradorligini bozor spekulyatsiyasidan ajratish imkonini beradi. Quantum BioPharma Ltd (QNTM) uchun ushbu ko'rsatkich beqarorligicha qolmoqda, chunki klinik tadqiqotlar bosqichida barqaror savdoning yo'qligi kompaniyani tashqi moliyalashtirishga bog'liq qilib qo'ygan.

Raqobatchilar tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.